GALLIVAC IBD

Nazione: Irlanda

Lingua: inglese

Fonte: HPRA (Health Products Regulatory Authority)

Principio attivo:

Infectious bursal disease virus, attenuated strain S706

Commercializzato da:

Boehringer Ingelheim Vetmedica GmbH

Codice ATC:

QI01AD09

INN (Nome Internazionale):

Infectious bursal disease virus, attenuated strain S706

Dosaggio:

.

Forma farmaceutica:

Lyophilisate for oculonasal suspension/use in drinking water

Tipo di ricetta:

POM: Prescription Only Medicine as defined in relevant national legislation

Area terapeutica:

avian infectious bursal disease virus (gumboro disease)

Stato dell'autorizzazione:

Authorised

Data dell'autorizzazione:

2006-12-21

Scheda tecnica

Health Products Regulatory Authority
15 July 2020
CRN009VN8
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
GALLIVAC IBD
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each dose contains:
Active ingredient:
Infectious Bursal Disease virus, attenuated strain S706, at least 10
4.0
CCID
50
Excipient:
qs 1 dose
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Lyophilisate for suspension
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Chickens (broilers, future layers and broiler breeders).
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Active immunisation of chickens to protect against mortality and to
reduce lesions associated with Infectious Bursal (Gumboro)
Disease. Immunity has been demonstrated 2 weeks after the first
administration and has been shown under field conditions to
persistthroughout the rearing period.
4.3 CONTRAINDICATIONS
Do not vaccinate unhealthy birds.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Due to the spread of the vaccine virus, it is recommended to separate
vaccinated and unvaccinated birds.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDICINAL PRODUCT TO ANIMALS
During spray administration, the eyes must be protected by safety
goggles and the nose and mouth by a dust mask. A helmet
with filtered air circulation may be used instead of goggles and a
mask.Care should be taken during reconstitution of the
vaccine and drinking water application. Hands should be washed and
disinfected after vaccinating.
4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
Laboratory studies have shown that when the vaccine virus was
experimentally passed from bird to bird, damage to the bursa
increased. This was detected by histological examination of the
bursae. However, this is not considered to result in an
immunosuppressive effect.
Health Products Regulatory Authority
15 July 2020
CRN009VN8
Page 2 of 4
4.7 USE DURING PREGNANCY, LACTATION OR L